Literature DB >> 7894002

Early dietary protein restriction slows disease progression and lengthens survival in mice with polycystic kidney disease.

K Tomobe1, D Philbrick, H M Aukema, W F Clark, M R Ogborn, A Parbtani, H Takahashi, B J Holub.   

Abstract

The objective of these studies was to examine the effects of early dietary protein restriction on disease progression and survival in the DBA/2FG-pcy (pcy) mouse model of polycystic kidney disease. Male pcy mice of 70 days of age were fed either a normal protein (NP, 25% casein) or a low-protein (LP, 6% casein) diet for 105 days. At the end of the dietary treatment, kidney weight, kidney weight relative to body weight and kidney water contents were almost 50% lower, and relative renal phospholipid and triglyceride contents were almost 50% higher, in mice fed the LP diet, indicating a marked reduction in the progression of cystic disease. Morphometric analyses also revealed a lower total and percent cyst area in kidneys derived from mice on the LP compared with the NP diet. There were no significant differences in final body weight, urine volume and osmolality, GFR, proteinuria, or plasma levels of protein and urea between these two groups. In a second study, it was found that all mice fed an NP diet from 70 days of age onward had died by 310 days of age, compared with a 42% survival rate in LP-fed mice at this age. Overall, the mean lifespan for pcy mice on the LP diet was 24% longer than that for those mice on the NP diet (310 +/- 20 versus 251 +/- 16 days; P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7894002     DOI: 10.1681/ASN.V561355

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  9 in total

1.  Ketosis Ameliorates Renal Cyst Growth in Polycystic Kidney Disease.

Authors:  Jacob A Torres; Samantha L Kruger; Caroline Broderick; Tselmeg Amarlkhagva; Shagun Agrawal; John R Dodam; Michal Mrug; Leslie A Lyons; Thomas Weimbs
Journal:  Cell Metab       Date:  2019-10-17       Impact factor: 27.287

2.  Urinary MCP1 and Microalbumin increase prior to onset of Azotemia in mice with polycystic kidney disease.

Authors:  Naomi A Kirby; Aaron M Stepanek; Andyna Vernet; Sarah M Schmidt; Carrie L Schultz; Nicola Ma Parry; Steven M Niemi; James G Fox; Diane E Brown
Journal:  Comp Med       Date:  2014-04       Impact factor: 0.982

3.  Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Lauren Pickel; Ioan-Andrei Iliuta; James Scholey; York Pei; Hoon-Ki Sung
Journal:  Adv Nutr       Date:  2021-11-10       Impact factor: 8.701

4.  Modulation of renal injury in pcy mice by dietary fat containing n-3 fatty acids depends on the level and type of fat.

Authors:  Deepa Sankaran; Jing Lu; Neda Bankovic-Calic; Malcolm R Ogborn; Harold M Aukema
Journal:  Lipids       Date:  2004-03       Impact factor: 1.880

5.  A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease.

Authors:  Kevin R Kipp; Mina Rezaei; Louis Lin; Elyse C Dewey; Thomas Weimbs
Journal:  Am J Physiol Renal Physiol       Date:  2016-01-13

Review 6.  Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential.

Authors:  Kristen L Nowak; Katharina Hopp
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-21       Impact factor: 8.237

Review 7.  Nutritional therapy in autosomal dominant polycystic kidney disease.

Authors:  Biagio R Di Iorio; Adamasco Cupisti; Claudia D'Alessandro; Antonio Bellasi; Vincenzo Barbera; Luca Di Lullo
Journal:  J Nephrol       Date:  2018-01-17       Impact factor: 3.902

Review 8.  The pathobiology of polycystic kidney disease from a metabolic viewpoint.

Authors:  Luis Fernando Menezes; Gregory G Germino
Journal:  Nat Rev Nephrol       Date:  2019-09-05       Impact factor: 28.314

Review 9.  Dietary Restriction for Kidney Protection: Decline in Nephroprotective Mechanisms During Aging.

Authors:  Nadezda V Andrianova; Marina I Buyan; Anastasia K Bolikhova; Dmitry B Zorov; Egor Y Plotnikov
Journal:  Front Physiol       Date:  2021-07-06       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.